The Role of Cannabinoids in Reducing Anxiety
Author Information
Author(s): F. A. Moreira, D. C. Aguiar, A. C. Campos, S. F. Lisboa, A. L. Terzian, L. B. Resstel, F. S. Guimarães
Primary Institution: Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo
Hypothesis
Do cannabinoids affect anxiety responses through the periaqueductal gray (PAG)?
Conclusion
The study suggests that cannabinoids can reduce anxiety-like behaviors through their action in the PAG.
Supporting Evidence
- Local administration of CB1 agonists in the PAG produced anxiolytic-like effects in rats.
- AEA injections into the dlPAG increased exploration in the elevated plus maze, indicating reduced anxiety.
- Contradictory results were observed in different anxiety models, suggesting complex interactions.
- CBD also showed anxiolytic-like effects in the PAG, potentially through 5HT1A receptor activation.
Takeaway
Cannabinoids, like those found in cannabis, can help calm down feelings of fear and anxiety by working in a specific part of the brain called the PAG.
Methodology
The study involved administering cannabinoid agonists directly into the PAG of rats and observing their behavior in various anxiety models.
Limitations
The study primarily used animal models, which may not fully translate to human anxiety responses.
Participant Demographics
Rats were used as the primary subjects in the experiments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website